| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Povednost rutinske uporabe testa na prikrito krvavitev v bolnišničnem okolju
Authors:ID Ravnik, Simona (Author)
ID Skalicky, Marjan (Author)
ID Skok, Pavel (Author)
Files:URL http://www.dlib.si/details/URN:NBN:SI:doc-WSQ3M5TS
 
Language:Slovenian
Work type:Not categorized
Typology:1.01 - Original Scientific Article
Organization:UM - University of Maribor
Abstract:Izhodišča. Pregled blata na prikrito krvavitev, hematest, sodi med uveljavljene presejalne metode za odkrivanje različnih bolezni prebavne cevi. V preteklosti je bila v randomiziranih raziskavah dokazana uporabnost te enostavne preiskave, ki lahko pomembno usmerja diagnostični postopek. Bolniki in metode. V naši retrospektivni analizi smo upoštevali bolnike, ki smo jih bolnišnično zdravili na oddelku za gastroenterologijo in endoskopijo Splošne bolnišnice Maribor v zadnjem četrtletju leta 2005 in pri katerih smo opravili test na prikrito krvavitev. Rezultati. Pregledali smo 200 bolnikov, 104 ženske in 96 moških povprečne starosti 63,9 leta, SD +/- 16,9, v razponu od 21 do 97 let. Pozitiven test na prikrito krvavitev smo ugotovili pri 76 bolnikih (38%). Pri 37 bolnikih (48,6 % vseh pozitivnih hematestov) smo dokazali krvavitev iz zgornjih prebavil in pri 34 bolnikih (46 % vseh pozitivnih hematestov) izvor krvavitve v spodnji prebavni cevi. Pri slednjih je bil najpogostejši vzrok kronična vnetna črevesna bolezen s 13,1 %, sledil je rak debelega črevesa in danke z 10,5 % in polipi debelega črevesa in danke s 6,6 %. Pri petih bolnikih (6,6 % vseh pozitivnih hematestov) nismo odkrili vira krvavitve kljub skrbnemu diagnostičnemu postopku. Zaključki. S presejalnimi testi na prikrito krvavitev v blatu, ki jih izvajamo med osebami brez kliničnih težav, lahko bistveno prispevamo k ciljanim diagnostičnim postopkom in zgodnjemu odkrivanju nekaterih bolezni prebavil, tudi raka debelega črevesa in danke v zgodnji, še omejeni obliki, ko je možnost ozdravitve največja.
Year of publishing:2006
Number of pages:str. II-49 - II-53
Numbering:Letn. 75, supl. II
PID:20.500.12556/DKUM-56251 New window
UDC:616.3-074
ISSN on article:1318-0347
COBISS.SI-ID:2490687 New window
NUK URN:URN:SI:UM:DK:EHZAC3S3
Publication date in DKUM:21.12.2015
Views:1192
Downloads:46
Metadata:XML DC-XML DC-RDF
Categories:Misc.
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Zdravniški vestnik. glasilo Slovenskega zdravniškega društva
Publisher:Slovensko zdravniško društvo
ISSN:1318-0347
COBISS.SI-ID:32893696 New window

Secondary language

Language:English
Title:Usefullnes of routine use of fecal occult blood test in a hospital setting
Abstract:Background. Fecal occult blood test, hematest, is a well excepted non-invasive method used for detecting different diseases of the gastrointestinal tract. It was proven in different randomized studies that usage of this simple method may facilitate further diagnostic and therapeutic treatment. Patients and methods. The retrospective analysis includes patients, which were admitted to the gastroenterological and endoscopy department of the General hospital Maribor in the last quarter of the year 2005. In all patients fecal occult blood test was performed. Results. We examined 200 patients, 104 women and 96 men, average age 63.9 years, SD +/- 16.9, ranging from 21 to 97 years. Positive hematest was discovered in 76 patients (38 %). The source of hemorrhage from the upper digestive tract was confirmed in 37 patients (48.6 % of all positive tests) and from the lower digestive tract in 34 patients (46 % of all positive tests). The most frequent causes of hemorrhage from the lower digestive tract were chronic inflammatory bowel disease (13.1 % of all positive tests), colorectal cancer (10.5 %) and polyps (6.6 %). The source of hemorrhage was not located in five patients (6.6 % of all positive tests) despite the accurate diagnostic procedure. Conclusions. By performing a fecal occult blood screening in non-symptomatic patients, we can make an essential step towards discovering different gastrointestinal diseases, even colorectal cancer in its early, limited form, when the effect of treatment is greatest.


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica